Bristol Myers Squibb (BMS) and Hengrui Pharma have entered into a major global strategic collaboration to advance a portfolio of... Read more
Tag: #M&A
OrganaBio Acquires Excellos Assets to Establish Coast-to-Coast Cell Therapy CDMO
OrganaBio has announced the substantial acquisition of all operating assets from San Diego-based Excellos. This move officially establishes a bicoastal... Read more
Leading Vietnamese pharmaceutical firms transition to foreign control
The Vietnamese pharmaceutical landscape is experiencing a significant influx of international capital, with nearly all top-tier firms by market capitalization... Read more
Livzon Group completes acquisition, securing majority control of Imexpharm Pharmaceutical
The Vietnamese pharmaceutical landscape has seen a significant shift in corporate ownership at Imexpharm Pharmaceutical JSC (Ticker: IMP). As of... Read more
Angelini Pharma acquires Catalyst for $4.1B to fulfill U.S. growth ambitions
Angelini Pharma, a historic Italian family-owned company, has announced a $4.1 billion agreement to acquire Florida-based Catalyst Pharmaceuticals. This marks... Read more
Roche to acquire PathAI for over $1 billion to transform AI-driven diagnostics
Roche has announced a definitive merger agreement to acquire PathAI, a leader in digital pathology and AI-powered technology. This acquisition... Read more
Bayer to acquire Perfuse for up to $2.45B to bolster its ophthalmology pipeline
Bayer has agreed to acquire San Francisco-based biotech startup Perfuse Therapeutics in a deal potentially worth $2.45 billion. This marks... Read more
Merck completes $5.8 billion acquisition of Terns Pharmaceuticals
Merck (known as MSD outside the U.S. and Canada) has announced the successful completion of its acquisition of Terns Pharmaceuticals.... Read more
Teva inks $900M Emalex buyout to expand Tourette syndrome pipeline
Teva Pharmaceuticals has proposed the acquisition of Emalex Biosciences, a move that integrates a promising pediatric Tourette syndrome therapy into... Read more








